catechin has been researched along with Endometrial Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TH; Kwong, J; Lau, TS; Leung, KT; Man, GCW; Ng, TB; Song, Y; Wang, CC; Wang, H; Wang, J; Wong, JH; Zhao, Y | 1 |
| Chen, HY; Chiang, YF; Hsia, SM; Huang, YJ; Wang, KL | 1 |
| Chan, TH; Kwong, J; Man, GCW; Wang, CC; Wang, J | 1 |
| Dann, JM; Evans, JJ; Mason, DR; Sykes, PH | 1 |
| Butler, LM; Wu, AH | 1 |
| Chitcholtan, K; Dann, JM; Evans, JJ; Guilford, P; Harris, G; Lewis, LK; Nagase, J; Sykes, PH; Welkamp, AA; Zwerus, R | 1 |
| Chandra, V; Dwivedi, A; Fatima, I; Manohar, M; Sankhwar, PL; Saxena, R | 1 |
2 review(s) available for catechin and Endometrial Neoplasms
| Article | Year |
|---|---|
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Humans; NF-E2-Related Factor 2; Ovarian Neoplasms; Protective Agents; Tea | 2020 |
Green and black tea in relation to gynecologic cancers.
Topics: Alphapapillomavirus; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Camellia sinensis; Catechin; Condylomata Acuminata; Endometrial Neoplasms; Female; Humans; Immunologic Factors; Ovarian Neoplasms; Papillomavirus Infections; Plant Leaves; Precancerous Conditions; Risk; Species Specificity; Tea; Uterine Cervical Neoplasms | 2011 |
5 other study(ies) available for catechin and Endometrial Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
Topics: Animals; Apoptosis; Catechin; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Mice; Mice, Nude; Prodrugs; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea | 2020 |
A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
Topics: Angiogenesis Inhibitors; Animals; Catechin; Cell Movement; Chemokine CXCL12; Endometrial Neoplasms; Female; Humans; Macrophages; Mice; Phosphoinositide-3 Kinase Inhibitors; Prodrugs; Tea; Vascular Endothelial Growth Factor A | 2018 |
Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG.
Topics: Anticarcinogenic Agents; Catechin; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2009 |
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Topics: Adenocarcinoma; Adrenomedullin; Biomarkers, Tumor; Case-Control Studies; Catechin; Cell Line, Tumor; Cobalt; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Grading; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |
(-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Endometrial Neoplasms; Female; Humans; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species | 2013 |